These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 12152684

  • 21. Effects of antithrombin and heparin cofactor II levels on anticoagulation with Intimatan.
    Tanaka KA, Szlam F, Vinten-Johansen J, Cardin AD, Levy JH.
    Thromb Haemost; 2005 Oct; 94(4):808-13. PubMed ID: 16270635
    [Abstract] [Full Text] [Related]

  • 22. Deletion mutagenesis of heparin cofactor II: defining the minimum size of a thrombin inhibiting serpin.
    Sheffield WP, Blajchman MA.
    FEBS Lett; 1995 May 29; 365(2-3):189-92. PubMed ID: 7781777
    [Abstract] [Full Text] [Related]

  • 23. Substitution of arginine for Leu444 in the reactive site of heparin cofactor II enhances the rate of thrombin inhibition.
    Derechin VM, Blinder MA, Tollefsen DM.
    J Biol Chem; 1990 Apr 05; 265(10):5623-8. PubMed ID: 2138609
    [Abstract] [Full Text] [Related]

  • 24. N-Acetylgalactosamine 4,6-O-sulfate residues mediate binding and activation of heparin cofactor II by porcine mucosal dermatan sulfate.
    Halldórsdóttir AM, Zhang L, Tollefsen DM.
    Glycobiology; 2006 Aug 05; 16(8):693-701. PubMed ID: 16624894
    [Abstract] [Full Text] [Related]

  • 25. Heparin cofactor II determination--levels in normals and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation.
    Tran TH, Duckert F.
    Thromb Haemost; 1984 Oct 31; 52(2):112-6. PubMed ID: 6395434
    [Abstract] [Full Text] [Related]

  • 26. Mechanism of activation of heparin cofactor II by calcium spirulan.
    Hayakawa Y, Hirashima Y, Yamamoto H, Kurimoto M, Hayashi T, Lee JB, Endo S.
    Arch Biochem Biophys; 2003 Aug 01; 416(1):47-52. PubMed ID: 12859981
    [Abstract] [Full Text] [Related]

  • 27. Mutagenesis of thrombin selectively modulates inhibition by serpins heparin cofactor II and antithrombin III. Interaction with the anion-binding exosite determines heparin cofactor II specificity.
    Sheehan JP, Wu Q, Tollefsen DM, Sadler JE.
    J Biol Chem; 1993 Feb 15; 268(5):3639-45. PubMed ID: 8429040
    [Abstract] [Full Text] [Related]

  • 28. Comparison of heparin- and dermatan sulfate-mediated catalysis of thrombin inactivation by heparin cofactor II.
    Liaw PC, Austin RC, Fredenburgh JC, Stafford AR, Weitz JI.
    J Biol Chem; 1999 Sep 24; 274(39):27597-604. PubMed ID: 10488098
    [Abstract] [Full Text] [Related]

  • 29. Aspartic acid residues 72 and 75 and tyrosine-sulfate 73 of heparin cofactor II promote intramolecular interactions during glycosaminoglycan binding and thrombin inhibition.
    Mitchell JW, Church FC.
    J Biol Chem; 2002 May 31; 277(22):19823-30. PubMed ID: 11856753
    [Abstract] [Full Text] [Related]

  • 30. RNA aptamer to thrombin binds anion-binding exosite-2 and alters protease inhibition by heparin-binding serpins.
    Jeter ML, Ly LV, Fortenberry YM, Whinna HC, White RR, Rusconi CP, Sullenger BA, Church FC.
    FEBS Lett; 2004 Jun 18; 568(1-3):10-4. PubMed ID: 15196911
    [Abstract] [Full Text] [Related]

  • 31. Role of thrombin anion-binding exosite-I in the formation of thrombin-serpin complexes.
    Myles T, Church FC, Whinna HC, Monard D, Stone SR.
    J Biol Chem; 1998 Nov 20; 273(47):31203-8. PubMed ID: 9813026
    [Abstract] [Full Text] [Related]

  • 32. Molecular cloning and expression of rabbit heparin cofactor II: a plasma thrombin inhibitor highly conserved between species.
    Sheffield WP, Schuyler PD, Blajchman MA.
    Thromb Haemost; 1994 Jun 20; 71(6):778-82. PubMed ID: 7974347
    [Abstract] [Full Text] [Related]

  • 33. Heparin cofactor II modulates the response to vascular injury.
    Tollefsen DM.
    Arterioscler Thromb Vasc Biol; 2007 Mar 20; 27(3):454-60. PubMed ID: 17194895
    [Abstract] [Full Text] [Related]

  • 34. Amino acid residues of heparin cofactor II required for stimulation of thrombin inhibition by sulphated polyanions.
    Colwell NS, Grupe MJ, Tollefsen DM.
    Biochim Biophys Acta; 1999 Apr 12; 1431(1):148-56. PubMed ID: 10209287
    [Abstract] [Full Text] [Related]

  • 35. Molecular mapping of the thrombin-heparin cofactor II complex.
    Fortenberry YM, Whinna HC, Gentry HR, Myles T, Leung LL, Church FC.
    J Biol Chem; 2004 Oct 08; 279(41):43237-44. PubMed ID: 15292227
    [Abstract] [Full Text] [Related]

  • 36. Structure-function relationships in heparin cofactor II: spectral analysis of aromatic residues and absence of a role for sulfhydryl groups in thrombin inhibition.
    Church FC, Meade JB, Pratt CW.
    Arch Biochem Biophys; 1987 Dec 08; 259(2):331-40. PubMed ID: 3426230
    [Abstract] [Full Text] [Related]

  • 37. Genetic variants and evolutionary analyses of heparin cofactor II.
    Kumar A, Bhandari A, Sarde SJ, Goswami C.
    Immunobiology; 2014 Sep 08; 219(9):713-28. PubMed ID: 24950623
    [Abstract] [Full Text] [Related]

  • 38. Molecular and cellular basis for type I heparin cofactor II deficiency (heparin cofactor II Awaji).
    Kondo S, Tokunaga F, Kario K, Matsuo T, Koide T.
    Blood; 1996 Feb 01; 87(3):1006-12. PubMed ID: 8562924
    [Abstract] [Full Text] [Related]

  • 39. Adenovirus-mediated expression of heparin cofactor II inhibits thrombin-induced cellular responses in fibroblasts and vascular smooth muscle cells.
    Hayakawa Y, Hirashima Y, Yamamoto H, Hayashi N, Kurimoto M, Kuwayama N, Endo S.
    Thromb Res; 2005 Feb 01; 116(4):357-63. PubMed ID: 16038721
    [Abstract] [Full Text] [Related]

  • 40. The interaction of glycosaminoglycans with heparin cofactor II: structure and activity of a high-affinity dermatan sulfate hexasaccharide.
    Tollefsen DM.
    Adv Exp Med Biol; 1992 Feb 01; 313():167-76. PubMed ID: 1442260
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.